Our Approach to Obstetrical Ultrasound & Fetal Medicine
Montefiore Einstein Obstetrical Ultrasound and Fetal Medicine is a global leader, providing comprehensive, state-of-the-art care for the full range of fetal conditions—from common concerns to the most complex anomalies—including abdominal wall defects, twin-to-twin transfusion syndrome (TTTS), congenital diaphragmatic hernia, fetal growth restriction and complex abnormalities of the brain, lungs and heart. Our multidisciplinary team includes world-renowned physicians who are double board certified in obstetrics and gynecology and maternal-fetal medicine, specializing in the prenatal diagnosis and management of fetal conditions. Our team provides care that is designed to optimize fetal health and support maternal well-being throughout both routine and high-risk pregnancies. We work closely with specialists in neonatology, pediatric cardiology, pediatric surgery, obstetric anesthesiology, obstetric critical care, reproductive and medical genetics and other specialties to deliver seamless, coordinated, patient- and family-centered care.
We are an international referral center for the most complex and high-risk pregnancies—including those involving placenta accreta spectrum (PAS)—and are recognized among the highest performing hospitals in the nation for maternity care, according to U.S. News & World Report. We are a designated Regional Perinatal Center (RPC) and Level 4 Neonatal Intensive Care Unit (NICU) from the New York State Department of Health —one of only 17 RPCs in New York State and one of just 127 Level 4 NICUs nationwide.
Montefiore Einstein is one of the few hospitals nationwide offering advanced in utero fetal surgeries for high-risk, rare and life-threatening conditions before birth to improve neonatal outcomes. Utilizing the most advanced diagnostic technologies and fetal therapies available, we develop individualized care plans to ensure the best possible outcomes for both mother and baby. Our expertise includes fetoscopic laser surgery for TTTS, radiofrequency ablation (RFA) for twin reversed arterial perfusion (TRAP) sequence, ex utero intrapartum treatment (EXIT) procedures, selective reductions, intrauterine transfusions and shunt placement for bladder or chest drainage. From prenatal diagnosis through delivery and beyond, we are committed to ensuring the safest possible pregnancies and deliveries, providing the highest quality care, optimizing outcomes and promoting the long-term health and well-being of every mother and child.
At the Forefront of Advanced Fetal Diagnostics
We offer comprehensive, same-day fetal diagnostic services—including first-trimester fetal anatomy scans, fetal echocardiography, neurosonography and a full range of prenatal genetic testing. Using state-of-the-art imaging technologies—including high-resolution 3D and 4D ultrasound and Doppler flow studies—our team provides detailed, real-time assessments of fetal anatomy, development, cardiovascular and neurologic function and overall well-being to guide personalized care planning, delivery strategies and timely interventions. Our commitment to excellence in advanced fetal diagnostics enables early detection, supports informed decision-making and promotes the best possible outcomes for both mother and baby.
We are also accredited by the American Institute of Ultrasound in Medicine (AIUM), demonstrating that we exceed nationally recognized standards for the performance and interpretation of diagnostic obstetric and gynecologic ultrasound examinations—and underscoring our commitment to clinical excellence and the highest quality of care. In addition, all of our diagnostic medical sonographers are certified by the American Registry for Diagnostic Medical Sonography (ARDMS), ensuring the highest standards in diagnostic imaging and patient care.
Advancing Care Through Early Detection
Early diagnosis gives families the time to explore their options, meet with our fetal medicine specialists and thoughtfully prepare for complex interventions or specialized deliveries, if needed. Advances in fetal imaging and genetic testing—including chromosomal microarray analysis and next-generation sequencing—allow for the earlier identification of hundreds of genetic syndromes, structural fetal conditions, functional abnormalities and placental disorders such as PAS, placenta previa and other abnormalities of placentation or implantation—empowering families with critical information and a fuller range of choices for care and decision-making.
Excelencia clínica
As a premier academic health system with a specialized Accreta Center, our New York State Department of Health designations as a RPC and Level 4 NICU reflect our commitment to delivering the highest level of maternal and neonatal care for newborns and women with the most complex and high-risk conditions. These distinctions are a testament to our leadership in advanced fetal medicine, high-risk pregnancy management and the exceptional expertise, care and support we provide to all women.
Diagnóstico y tratamientos avanzados
We offer access to the latest diagnostic technologies, advanced monitoring and innovative treatments to deliver the highest-quality prenatal care for mother and baby.
Our expert team provides comprehensive fetal monitoring and diagnostic evaluations—including biophysical profiles, nonstress tests and Doppler ultrasound studies—to assess fetal well-being, identify potential fetal health risks and guide the development of individualized care plans. We utilize state-of-the-art imaging technologies such as 3D and 4D obstetrical ultrasound, targeted fetal echocardiography, fetal neurosonography and fetal magnetic resonance imaging (MRI), for detailed evaluation of brain, cardiac, thoracic and abdominal anomalies, as well as uterine artery Doppler assessments for early detection of preeclampsia risk.
Our advanced noninvasive prenatal genetic diagnostics include carrier screening before and during pregnancy, first-trimester risk assessment and combined screening, second-trimester quadruple and penta screening and cell-free deoxyribonucleic acid (cfDNA) analysis—commonly referred to as noninvasive prenatal testing (NIPT)—primarily used to screen for common fetal abnormalities such as trisomy 21 (Down syndrome), trisomy 18 and trisomy 13, utilizing next-generation sequencing (NGS) technology. We also specialize in minimally invasive prenatal diagnostic procedures, including chorionic villus sampling, amniocentesis and cordocentesis, supported by chromosomal microarray analysis and, when indicated, diagnostic NGS.
Our specialists support pregnancies requiring advanced medical intervention. This includes coordinated management for PAS, severe preeclampsia or fetal anomalies requiring EXIT procedures. When needed, patients have access to advanced maternal support technologies at our birthing sites—including extracorporeal membrane oxygenation (ECMO) and complex cardiac monitoring—in order to ensure seamless, multidisciplinary care for both mother and baby.
Our team provides specialized care for the full range of fetal conditions, offering advanced diagnostics and therapies, including:
Investigación
Lideramos iniciativas de investigación colaborativa y encabezamos numerosos estudios y ensayos clínicos, incluidos varios financiados por los Institutos Nacionales de Salud (NIH, por sus siglas en inglés). Gracias a nuestros ensayos clínicos, los pacientes tienen acceso a tecnologías emergentes y tratamientos innovadores que, de otro modo, podrían no estar disponibles para el público en general.
Nuestros investigadores llevan a cabo investigaciones básicas, traslacionales y clínicas para avanzar en la medicina fetal y mejorar los resultados tanto para la madre como para el bebé. Las áreas clave de interés incluyen la genética fetal y la biología del desarrollo, el cribado y el diagnóstico genético prenatal, la detección temprana de anomalías estructurales mediante ecografías avanzadas, las terapias fetales para embarazos de alto riesgo y la integración de la medicina genómica en la atención médica prenatal. También estamos desarrollando y evaluando nuevas estrategias diagnósticas y terapéuticas, como las tecnologías de monitorización fetal no invasivas y las intervenciones novedosas para prevenir el parto prematuro.
In collaboration with our Department of Genetics, our basic science programs are advancing cellular and molecular research—from uncovering mechanisms that contribute to birth defects in 22q11.2 deletion syndrome (22q11.2DS) to leading the nation’s largest pilot newborn screening study of its kind.
Our team has led numerous studies in fetal medicine and prenatal diagnostics. As global principal investigators of the SNP-based Microdeletion and Aneuploidy RegisTry (SMART) Study—the largest multicenter prospective noninvasive prenatal testing (NIPT) study ever conducted and the first large-scale study to collect genetic outcomes in most participants—we investigated the performance of cfDNA screening for the prenatal detection of 22q11.2DS and how high-risk screening results for 22q11.2DS influenced obstetric and neonatal management. We also assessed obstetrical, perinatal and genetic outcomes associated with nonreportable cfDNA screening results.
Additional work includes evaluating the clinical utility of expanded NIPT, the impact of the routine implementation of cfDNA aneuploidy screening on the performance of first-trimester ultrasound and the development of an AI model for early prediction of preeclampsia using cfDNA biomarkers and patient data. In placenta accreta spectrum (PAS) research, we investigated first-trimester screening and used machine learning for the prediction of PAS-related surgical morbidity. We also studied the association between second-trimester fetal abdominal circumference and the prediction of small for gestational age at birth, and examined the association of third-trimester resolution of low placentation and other prenatal ultrasound markers and postpartum hemorrhage with delivery.
Servicios de orientación y apoyo en la atención médica
Whether you are planning for pregnancy, navigating a high-risk pregnancy or seeking advanced fetal care, our world-renowned team at Montefiore Einstein Fetal Medicine and Ultrasound is here to provide exceptional support, care and resources tailored to your needs.
Nuestro centro de servicios integrales ofrece una amplia gama de cuidados tradicionales y holísticos antes, durante y después del embarazo, que abarca desde el asesoramiento previo a la concepción, las pruebas de detección y el examen prenatal, hasta el tratamiento y la recuperación posparto. Ofrecemos servicios integrados que incluyen programas sociales y de apoyo, asesoramiento y educación genética, orientación sobre atención médica, apoyo para la salud mental y el bienestar, y programas personalizados diseñados para satisfacer las necesidades únicas de cada persona.
Somos un hospital que acepta y ofrece servicios de doulas para apoyar a las personas durante el trabajo de parto, el alumbramiento y la atención posparto, lo que ayuda a garantizar los mejores resultados posibles en el parto y la mejor experiencia para la paciente. Nuestro Programa Mujeres, Bebés y Niños (WIC, por sus siglas en inglés) apoya la salud de las mujeres, los bebés y los niños de hasta 5 años con bajos ingresos que se encuentran en riesgo nutricional, y les ofrece alimentos nutritivos gratis, apoyo a la lactancia materna, educación nutricional y derivaciones a servicios sociales y de atención médica.
También disponemos de una gran variedad de programas comunitarios de salud materno-infantil, que constan de Bronx Healthy Start, HealthySteps y Nurse-Family Partnership, entre otros, cuyo objetivo es dar a las familias una atención médica integral, educación y recursos desde el embarazo hasta la primera infancia, a través de servicios integrados que van más allá de la consulta médica.
Our breadth of resources enables us to deliver highly specialized, coordinated care for both mother and baby—advancing fetal health, supporting maternal well-being, optimizing outcomes and ensuring a healthy pregnancy and the safest delivery possible. Our compassionate and deeply knowledgeable team of physicians, nurses, specialists and support staff is dedicated to guiding you at every step of your pregnancy and fetal care journey.
Su equipo de ultrasonido obstétrico y medicina fetal
Peer Dar, MD
Nuestro equipo multidisciplinario está formado por médicos de renombre mundial que son colegiados en obstetricia y ginecología y medicina materno-fetal, con experiencia subespecializada en medicina y ecografía fetal. Ofrecemos una atención integral y personalizada centrada en el diagnóstico y tratamiento de afecciones fetales complejas. Colaboramos estrechamente para garantizar embarazos y partos lo más seguros posible, optimizar los resultados neonatales y promover la salud y el bienestar a largo plazo de la madre y el bebé.
Programas e iniciativas comunitarias transformadoras
Nuestro programa es reconocido por su enfoque colaborativo y su atención médica integral, que se extiende más allá de las paredes de Montefiore Einstein a la comunidad a través de programas de divulgación destinados a reducir los riesgos obstétricos entre las poblaciones vulnerables. Entre las iniciativas específicas figuran la educación comunitaria sobre atención prenatal y gestión de embarazos de alto riesgo, la colaboración con hospitales locales para mejorar la atención continuada de madres de alto riesgo y la participación en la elaboración de políticas relacionadas con la salud materna. Seguimos ampliando el acceso a la atención médica para mejorar la salud maternoinfantil, preservar la continuidad asistencial y reducir las disparidades que afectan a mujeres, niños y familias.
Colaboramos con una red de organizaciones comunitarias para mejorar los resultados perinatales, reducir la morbilidad y la mortalidad materna e infantil y fortalecer la infraestructura de atención médica en nuestra comunidad. A través del Instituto de Trabajadores Comunitarios de la Salud (CHWI, por sus siglas en inglés) de Montefiore Einstein, seguimos optimizando la integración de los trabajadores comunitarios de la salud en nuestros equipos clínicos para fortalecer los recursos, mejorar la coordinación de la atención y el acceso, así como los resultados en salud.
One of the unique programs we have spearheaded is called the Bronx Healthy Start Program (BxHSP), a federally-funded program of the Health Resources and Services Administration (HRSA) Maternal & Child Health Bureau that helps pregnant women get the healthcare and support they need during pregnancy and after their baby is born. Mothers and their families are connected to free, voluntary and confidential services including screening and referral for medical services, voluntary home visitation and other resources.
We also offer numerous other community-based maternal and child health programs. HealthySteps supports families by addressing children’s developmental and behavioral needs through integrated, team-based care within the pediatric setting. The Nurse-Family Partnership is a program for low-income, first-time parents, providing home visits and ongoing support from registered nurses during pregnancy until the child turns two years old to improve prenatal, maternal and child health, birth outcomes and early childhood development.
El programa de salud para el embarazo y el posparto God’s Love We Deliver ofrece asistencia a las mujeres embarazadas de alto riesgo con diabetes gestacional o preexistente y trastornos hipertensivos del embarazo mediante terapia nutricional médica, educación y asesoramiento nutricional, y comidas nutritivas y adaptadas médicamente, que se suministran durante todo el embarazo y el posparto para promover resultados positivos para la salud tanto de los padres como de los hijos.
Estos son solo algunos de los muchos programas innovadores que ofrecemos para acompañar a las familias durante el embarazo y la primera infancia.
About Fetal Conditions
Fetal conditions encompass a broad range of anomalies and complications that can affect a baby’s development during pregnancy. These may involve the abdominal wall (e.g., gastroschisis, omphalocele), gastrointestinal tract (e.g., bowel or esophageal atresia), genitourinary system (e.g., lower urinary tract obstruction, renal anomalies, polycystic kidney disease), lungs and diaphragm (e.g., congenital diaphragmatic hernia), brain and spine (e.g., congenital brain anomalies, neural tube defects), heart (e.g., fetal arrhythmias, congenital heart defects), and musculoskeletal system (e.g., clubfoot, skeletal dysplasias). Additional concerns include craniofacial anomalies (e.g., cleft lip and cleft palate), hematologic disorders such as fetal anemia, and immune-related conditions like maternal alloimmunization. Some conditions result from chromosomal or genetic abnormalities (e.g., Down syndrome, Edwards syndrome, Patau syndrome, Turner syndrome), while others arise from fetal infections, tumors, fetal growth restriction, or complications of multiple gestations. Advances in prenatal imaging and diagnostics now allow many of these conditions to be identified as early as the first or second trimester. While some congenital anomalies can be effectively managed after birth, others may benefit from close fetal monitoring, in utero treatment, or specialized delivery planning. Early diagnosis enables informed decision-making, coordinated perinatal care, and personalized treatment strategies—which may help to optimize outcomes for infants with complex medical needs.
Afecciones fetales que tratamos
Many conditions once considered untreatable can now be diagnosed, managed or even corrected before birth—transforming the outlook for families facing complex fetal diagnoses. While most congenital conditions can be effectively treated after delivery, early prenatal diagnosis, coordinated delivery planning and specialized pre- and postnatal care significantly improve early detection, stabilization and long-term outcomes for infants with complex health needs.
At our Center, we offer comprehensive diagnostic evaluation and multidisciplinary care for a wide range of fetal conditions, including:
